Investigation of the Susceptibility to Inactivation of 2D6*1 and 2D6*53 by a Known Mechanism-Based Inactivator SCH 66712
MetadataShow full item record
Cytochrome P450s (P450s) are a superfamily of heme-containing enzymes that are responsible for the metabolism of many xenobiotics and other small endogenous substrates. CYP2D6 is a major P450 enzyme studied during drug development due to its ability to metabolize ~12-20% of all pharmaceuticals. Moreover, there are over 100 allelic variants of CYP2D6 resulting in a wide-range of drug responses among individuals including cases of adverse drug events. The inactivation of one allelic variant, 2D6*53, by a known-mechanism based inactivator, SCH 66712, was investigated in a time- and concentration-dependent manner alongside the reference *1. Though *1 was inactivated by SCH 66712, *53 was not susceptible to inactivation. The greatly decreased rate of inactivation of *53 suggests that inactivation may be dependent on time and positioning of inactivator in the active site. A trapping assay to capture any SCH 66712 reactive intermediates with NAC and GSH was performed, however, the results were inconclusive as analyzed by mass spectrometry.
Showing items related by title, author, creator and subject.
Investigation of CYP 2D6 Variants and their Susceptibility to Inactivation by the Known Mechanism-based Inactivator SCH66712 Osorio, Victoria M. (Kalamazoo College, 2015)Cytochrome P450s (CYPs) are a super family of heme-containing enzymes that in humans metabolize a variety of small molecules including drugs. Human CYP2D6 is responsible for the metabolism of ~12% of all pharmaceutical ...
Mechanism Based Inactivation of Cytochrome P450 3A4 by 5-Fluoro-2-[4-[(2-phenyl-1H- imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Bolles, Amanda K. (Kalamazoo College, 2013)Human cytochrome P450 3A4 (CYP3A4) is responsible for the metabolism of over fifty percent of pharmaceutical drugs on the market today. Inhibition of CYP3A4 can lead to adverse drug-drug interactions. 5-Fluoro-2-[4-[(2-p ...
A Novel Mutagenesis Strategy to Inactivate the Gene Encoding IgAl Protease in Neisseria gonorrhoeae for Use in the' Human Challenge Model Koymen, Hakan O. (Kalamazoo College, 1994)Immunoglobulin Al (IgAI) protease is believed to be a possible virulence factor of Neisseria gonorrhoeae. However, until this point it has been impossible to study the role of IgAl protease in vivo. To avoid the addition ...